MedPath
HSA Approval

BISOHEXAL TABLET 5 mg

SIN12568P

BISOHEXAL TABLET 5 mg

BISOHEXAL TABLET 5 mg

July 21, 2004

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C07AB07

bisoprolol

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

SALUTAS PHARMA GMBH

LEK S.A.

LEK S.A. (Warszawa) (Primary and Secondary Packager)

Active Ingredients

BISOPROLOL FUMARATE

5 mg

Bisoprolol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BISOHEXAL TABLET 5 mg - HSA Approval | MedPath